176 results on '"Ramadori, Pierluigi"'
Search Results
2. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
3. A researcher’s guide to preclinical mouse NASH models
4. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease
5. The immunological and metabolic landscape in primary and metastatic liver cancer
6. XCR1.sup.+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
7. Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
8. Beneficial effects of intermittent fasting in NASH and subsequent HCC development are executed by concerted PPAR alpha and PCK1 action in hepatocytes
9. Platelets in chronic liver disease, from bench to bedside
10. Publisher Correction: XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
11. Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
12. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease
13. Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression
14. NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy
15. Hepatocytes
16. T cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
17. Guidelines and Considerations for Metabolic Tolerance Tests in Mice
18. Unique tumour microenvironment: when ferroptosis activation boosts ICI of liver cancer.
19. Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]
20. Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
21. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis
22. Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6
23. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
24. Phagocytosis of gadolinium chloride or zymosan induces simultaneous upregulation of hepcidin- and downregulation of hemojuvelin- and Fpn-1-gene expression in murine liver
25. Expression of stem cell factor and its receptor c-Kit during the development of intrahepatic cholangiocarcinoma
26. XCR1 + type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
27. Corrigendum to 'Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis' [J Hepatol 75 (2021) 865-878]
28. Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development
29. Melanocortin receptors in rat liver cells: change of gene expression and intracellular localization during acute-phase response
30. Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma
31. Solving problems is smart, preventing them is wise: Lessons learned from the 2nd International DKFZ Conference on Cancer Prevention
32. Guidelines and Considerations for Metabolic Tolerance Tests in Mice
33. Characterization of the erythropoietin/erythropoietin receptor axis in a rat model of liver damage and cholangiocarcinoma development: 878
34. Hepatocytes
35. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets
36. PKCλ/ι Loss Induces Metabolic Reprogramming in Liver Cancer: Hitting Two Birds with One Stone?
37. Novel patient-derived preclinical models of liver cancer
38. Reflectance confocal microscopy for noninvasive examination of nonmelanocytic tumors and virus‐associated skin lesions in organ transplant recipients
39. An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents
40. Hepatic changes of erythropoietin gene expression in a rat model of acute-phase response
41. FRI-089-Genetic deletion of Keap in hepatocytes improves liver damage, but triggers hepatitis in an Nrf2-dependent manner, in experimental toxic liver injury
42. THU-254-Cumulative effects of western diet and alcohol abuse: A novel model of ASH/NASH-derived liver injury
43. Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
44. Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH
45. Auto-aggressive CXCR6+CD8 T cells cause liver immune pathology in NASH
46. Reflectance confocal microscopy for noninvasive examination of nonmelanocytic tumors and virus‐associated skin lesions in organ transplant recipients.
47. XCR1+type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
48. Immunoregulation by lipids during the development of non-alcoholic steatohepatitis
49. Stress-activatedmiR-21/miR-21*in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption
50. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.